Email this article NEW CAPACITIES OF TARGETED THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
- Authors: Alekseyev B.Y.1, Kalpinsky A.S.1
-
Affiliations:
- P.A. Herzen Moscow Research Institute of Oncology
- Issue: Vol 5, No 3 (2009)
- Pages: 8-12
- Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER
- Published: 30.09.2009
- URL: https://oncourology.abvpress.ru/oncur/article/view/252
- DOI: https://doi.org/10.17650/1726-9776-2009-5-3-8-12
- ID: 252
Cite item
Full Text
Abstract
The efficacy and tolerability of temsirolimus are considered in patients with metastatic renal-cell carcinoma. The drug has been found to have a high antitumor activity and a good tolerability in patients with disseminated renal-cell carcinoma with a very poor prognosis and to cause few side effects.
About the authors
B. Ya. Alekseyev
P.A. Herzen Moscow Research Institute of Oncology
Author for correspondence.
Email: byalekseev@mail.ru
Russian Federation
A. S. Kalpinsky
P.A. Herzen Moscow Research Institute of Oncology
Email: byalekseev@mail.ru
Russian Federation
References
Supplementary files
